Overview

A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2028-12-30
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of the combination therapy of SH006 injection in patients with advanced solid tumors
Phase:
PHASE1
Details
Lead Sponsor:
Nanjing Sanhome Pharmaceutical, Co., Ltd.